Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis

Saskia C A De Jager, Beatriz Bermúdez, Ilze Bot, Rory R. Koenen, Martine Bot, Annemieke Kavelaars, Vivian De Waard, Cobi J. Heijnen, Francisco J G Muriana, Christian Weber, Theo J C Van Berkel, Johan Kuiper, Se Jin Lee, Rocio Abia, Erik A L Biessen

Research output: Contribution to journalArticle

Abstract

Growth differentiation factor (GDF) 15 is a member of the transforming growth factor β (TGF-β) superfamily, which operates in acute phase responses through a currently unknown receptor. Elevated GDF-15 serum levels were recently identified as a risk factor for acute coronary syndromes. We show that GDF-15 expression is up-regulated as disease progresses in murine atherosclerosis and primarily colocalizes with plaque macrophages. Hematopoietic GDF-15 deficiency in low density lipoprotein receptor-/- mice led to impaired initial lesion formation and increased collagen in later lesions. Although lesion burden in GDF-15-/- chimeras was unaltered, plaques had reduced macrophage infiltrates and decreased necrotic core formation, all features of improved plaque stability. In vitro studies pointed to a TGFβRII-dependent regulatory role of GDF-15 in cell death regulation. Importantly, GDF-15-/- macrophages displayed reduced CCR2 expression, whereas GDF-15 promoted macrophage chemotaxis in a strictly CCR2- and TGFβRII-dependent manner, a phenomenon which was not observed in G protein-coupled receptor kinase 2+/- macrophages. In conclusion, GDF-15 deletion has a beneficial effect both in early and later atherosclerosis by inhibition of CCR2-mediated chemotaxis and by modulating cell death. Our study is the first to identify GDF-15 as an acute phase modifier of CCR2/TGFβRII-dependent inflammatory responses to vascular injury.

Original languageEnglish (US)
Pages (from-to)217-225
Number of pages9
JournalJournal of Experimental Medicine
Volume208
Issue number2
DOIs
StatePublished - Feb 14 2011

Fingerprint

Growth Differentiation Factor 15
Chemotaxis
Atherosclerosis
Macrophages
Cell Death
G-Protein-Coupled Receptor Kinase 2
Acute-Phase Reaction
LDL Receptors
Vascular System Injuries
Transforming Growth Factors
Acute Coronary Syndrome

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

De Jager, S. C. A., Bermúdez, B., Bot, I., Koenen, R. R., Bot, M., Kavelaars, A., ... Biessen, E. A. L. (2011). Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. Journal of Experimental Medicine, 208(2), 217-225. https://doi.org/10.1084/jem.20100370

Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. / De Jager, Saskia C A; Bermúdez, Beatriz; Bot, Ilze; Koenen, Rory R.; Bot, Martine; Kavelaars, Annemieke; De Waard, Vivian; Heijnen, Cobi J.; Muriana, Francisco J G; Weber, Christian; Van Berkel, Theo J C; Kuiper, Johan; Lee, Se Jin; Abia, Rocio; Biessen, Erik A L.

In: Journal of Experimental Medicine, Vol. 208, No. 2, 14.02.2011, p. 217-225.

Research output: Contribution to journalArticle

De Jager, SCA, Bermúdez, B, Bot, I, Koenen, RR, Bot, M, Kavelaars, A, De Waard, V, Heijnen, CJ, Muriana, FJG, Weber, C, Van Berkel, TJC, Kuiper, J, Lee, SJ, Abia, R & Biessen, EAL 2011, 'Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis', Journal of Experimental Medicine, vol. 208, no. 2, pp. 217-225. https://doi.org/10.1084/jem.20100370
De Jager, Saskia C A ; Bermúdez, Beatriz ; Bot, Ilze ; Koenen, Rory R. ; Bot, Martine ; Kavelaars, Annemieke ; De Waard, Vivian ; Heijnen, Cobi J. ; Muriana, Francisco J G ; Weber, Christian ; Van Berkel, Theo J C ; Kuiper, Johan ; Lee, Se Jin ; Abia, Rocio ; Biessen, Erik A L. / Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis. In: Journal of Experimental Medicine. 2011 ; Vol. 208, No. 2. pp. 217-225.
@article{89086439af4d4e68b9c4d1f58fbddd33,
title = "Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis",
abstract = "Growth differentiation factor (GDF) 15 is a member of the transforming growth factor β (TGF-β) superfamily, which operates in acute phase responses through a currently unknown receptor. Elevated GDF-15 serum levels were recently identified as a risk factor for acute coronary syndromes. We show that GDF-15 expression is up-regulated as disease progresses in murine atherosclerosis and primarily colocalizes with plaque macrophages. Hematopoietic GDF-15 deficiency in low density lipoprotein receptor-/- mice led to impaired initial lesion formation and increased collagen in later lesions. Although lesion burden in GDF-15-/- chimeras was unaltered, plaques had reduced macrophage infiltrates and decreased necrotic core formation, all features of improved plaque stability. In vitro studies pointed to a TGFβRII-dependent regulatory role of GDF-15 in cell death regulation. Importantly, GDF-15-/- macrophages displayed reduced CCR2 expression, whereas GDF-15 promoted macrophage chemotaxis in a strictly CCR2- and TGFβRII-dependent manner, a phenomenon which was not observed in G protein-coupled receptor kinase 2+/- macrophages. In conclusion, GDF-15 deletion has a beneficial effect both in early and later atherosclerosis by inhibition of CCR2-mediated chemotaxis and by modulating cell death. Our study is the first to identify GDF-15 as an acute phase modifier of CCR2/TGFβRII-dependent inflammatory responses to vascular injury.",
author = "{De Jager}, {Saskia C A} and Beatriz Berm{\'u}dez and Ilze Bot and Koenen, {Rory R.} and Martine Bot and Annemieke Kavelaars and {De Waard}, Vivian and Heijnen, {Cobi J.} and Muriana, {Francisco J G} and Christian Weber and {Van Berkel}, {Theo J C} and Johan Kuiper and Lee, {Se Jin} and Rocio Abia and Biessen, {Erik A L}",
year = "2011",
month = "2",
day = "14",
doi = "10.1084/jem.20100370",
language = "English (US)",
volume = "208",
pages = "217--225",
journal = "Journal of Experimental Medicine",
issn = "0022-1007",
publisher = "Rockefeller University Press",
number = "2",

}

TY - JOUR

T1 - Growth differentiation factor 15 deficiency protects against atherosclerosis by attenuating CCR2-mediated macrophage chemotaxis

AU - De Jager, Saskia C A

AU - Bermúdez, Beatriz

AU - Bot, Ilze

AU - Koenen, Rory R.

AU - Bot, Martine

AU - Kavelaars, Annemieke

AU - De Waard, Vivian

AU - Heijnen, Cobi J.

AU - Muriana, Francisco J G

AU - Weber, Christian

AU - Van Berkel, Theo J C

AU - Kuiper, Johan

AU - Lee, Se Jin

AU - Abia, Rocio

AU - Biessen, Erik A L

PY - 2011/2/14

Y1 - 2011/2/14

N2 - Growth differentiation factor (GDF) 15 is a member of the transforming growth factor β (TGF-β) superfamily, which operates in acute phase responses through a currently unknown receptor. Elevated GDF-15 serum levels were recently identified as a risk factor for acute coronary syndromes. We show that GDF-15 expression is up-regulated as disease progresses in murine atherosclerosis and primarily colocalizes with plaque macrophages. Hematopoietic GDF-15 deficiency in low density lipoprotein receptor-/- mice led to impaired initial lesion formation and increased collagen in later lesions. Although lesion burden in GDF-15-/- chimeras was unaltered, plaques had reduced macrophage infiltrates and decreased necrotic core formation, all features of improved plaque stability. In vitro studies pointed to a TGFβRII-dependent regulatory role of GDF-15 in cell death regulation. Importantly, GDF-15-/- macrophages displayed reduced CCR2 expression, whereas GDF-15 promoted macrophage chemotaxis in a strictly CCR2- and TGFβRII-dependent manner, a phenomenon which was not observed in G protein-coupled receptor kinase 2+/- macrophages. In conclusion, GDF-15 deletion has a beneficial effect both in early and later atherosclerosis by inhibition of CCR2-mediated chemotaxis and by modulating cell death. Our study is the first to identify GDF-15 as an acute phase modifier of CCR2/TGFβRII-dependent inflammatory responses to vascular injury.

AB - Growth differentiation factor (GDF) 15 is a member of the transforming growth factor β (TGF-β) superfamily, which operates in acute phase responses through a currently unknown receptor. Elevated GDF-15 serum levels were recently identified as a risk factor for acute coronary syndromes. We show that GDF-15 expression is up-regulated as disease progresses in murine atherosclerosis and primarily colocalizes with plaque macrophages. Hematopoietic GDF-15 deficiency in low density lipoprotein receptor-/- mice led to impaired initial lesion formation and increased collagen in later lesions. Although lesion burden in GDF-15-/- chimeras was unaltered, plaques had reduced macrophage infiltrates and decreased necrotic core formation, all features of improved plaque stability. In vitro studies pointed to a TGFβRII-dependent regulatory role of GDF-15 in cell death regulation. Importantly, GDF-15-/- macrophages displayed reduced CCR2 expression, whereas GDF-15 promoted macrophage chemotaxis in a strictly CCR2- and TGFβRII-dependent manner, a phenomenon which was not observed in G protein-coupled receptor kinase 2+/- macrophages. In conclusion, GDF-15 deletion has a beneficial effect both in early and later atherosclerosis by inhibition of CCR2-mediated chemotaxis and by modulating cell death. Our study is the first to identify GDF-15 as an acute phase modifier of CCR2/TGFβRII-dependent inflammatory responses to vascular injury.

UR - http://www.scopus.com/inward/record.url?scp=79951708423&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79951708423&partnerID=8YFLogxK

U2 - 10.1084/jem.20100370

DO - 10.1084/jem.20100370

M3 - Article

C2 - 21242297

AN - SCOPUS:79951708423

VL - 208

SP - 217

EP - 225

JO - Journal of Experimental Medicine

JF - Journal of Experimental Medicine

SN - 0022-1007

IS - 2

ER -